{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T21:23:06Z","timestamp":1776547386656,"version":"3.51.2"},"reference-count":5,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007319","name":"Albert Einstein College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["fertstertreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["F&S Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.xfre.2024.11.001","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T07:09:48Z","timestamp":1731049788000},"page":"350-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Elagolix for ovulation suppression in in\u00a0vitro fertilization: Is it time to switch from the painful costly injectables?"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7952-1428","authenticated-orcid":false,"given":"Zaher","family":"Merhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xfre.2024.11.001_bib1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/09513590.2015.1014785","article-title":"Obesity adversely impacts the number and maturity of oocytes in conventional IVF not in minimal stimulation IVF","volume":"31","author":"Zhang","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.xfre.2024.11.001_bib2","first-page":"356","article-title":"The role of elagolix in ovulation suppression during controlled ovarian stimulation: a retrospective cohort study","volume":"5","author":"Soliman","year":"2024","journal-title":"F S Rep"},{"key":"10.1016\/j.xfre.2024.11.001_bib3","first-page":"179","article-title":"The role of elagolix in the suppression of ovulation in donor oocyte cycles","volume":"4","author":"Boniface","year":"2023","journal-title":"F S Rep"},{"key":"10.1016\/j.xfre.2024.11.001_bib4","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgae168","article-title":"Elagolix represents a less invasive and cheaper option than injectable GnRH antagonist for ovulation suppression in IVF","author":"Mouanness","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfre.2024.11.001_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-052043","article-title":"Pre-IVF treatment with a GnRH antagonist in women with endometriosis (PREGNANT): study protocol for a prospective, double-blind, placebo-controlled trial","volume":"12","author":"Taylor","year":"2022","journal-title":"BMJ Open"}],"container-title":["F&S Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266633412400120X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266633412400120X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:09:50Z","timestamp":1734566990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266633412400120X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S266633412400120X"],"URL":"https:\/\/doi.org\/10.1016\/j.xfre.2024.11.001","relation":{},"ISSN":["2666-3341"],"issn-type":[{"value":"2666-3341","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elagolix for ovulation suppression in in\u00a0vitro fertilization: Is it time to switch from the painful costly injectables?","name":"articletitle","label":"Article Title"},{"value":"F&S Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xfre.2024.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.xfre.2024.06.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}